Persson I - Search Results

1

What is the harm-benefit ratio of Cox-2 inhibitors?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Among authors: persson i. Int J Epidemiol. 2008 Apr;37(2):405-13. doi: 10.1093/ije/dym296. Epub 2008 Feb 8. Int J Epidemiol. 2008. PMID: 18263647

2

Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Among authors: persson i. Pharmacoepidemiol Drug Saf. 2008 May;17(5):475-84. doi: 10.1002/pds.1568. Pharmacoepidemiol Drug Saf. 2008. PMID: 18322905

3

Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval.

Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Egberts TC, Blackburn S, Persson I, Leufkens HG. Giezen TJ, et al. Among authors: persson i. Drug Saf. 2009;32(12):1175-87. doi: 10.2165/11318980-000000000-00000. Drug Saf. 2009. PMID: 19916584

4

Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N. Persson I, et al. J Intern Med. 2014 Feb;275(2):172-90. doi: 10.1111/joim.12150. Epub 2013 Nov 10. J Intern Med. 2014. PMID: 24134219 Free article.

5

Increased risk of abdominal wall hernia associated with combination anti-retroviral therapy in HIV-infected patients-results from a Swedish cohort-study.

Sundström A, Mortimer O, Akerlund B, Karlsson A, Flamholc L, Håkangård C, Granholm H, Persson I, Morfeldt L. Sundström A, et al. Among authors: persson i. Pharmacoepidemiol Drug Saf. 2010 May;19(5):465-73. doi: 10.1002/pds.1922. Pharmacoepidemiol Drug Saf. 2010. PMID: 20186997

6

Risk of myocardial infarction after oophorectomy and hysterectomy.

Falkeborn M, Schairer C, Naessén T, Persson I. Falkeborn M, et al. Among authors: persson i. J Clin Epidemiol. 2000 Aug;53(8):832-7. doi: 10.1016/s0895-4356(00)00187-6. J Clin Epidemiol. 2000. PMID: 10942866

7

Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens.

Bergkvist L, Persson I, Adami HO, Schairer C. Bergkvist L, et al. Among authors: persson i. Int J Epidemiol. 1988 Dec;17(4):732-7. doi: 10.1093/ije/17.4.732. Int J Epidemiol. 1988. PMID: 3225079

8

Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying rates.

Samuelsson E, Hedenmalm K, Persson I. Samuelsson E, et al. Among authors: persson i. Eur J Epidemiol. 2005;20(6):509-16. doi: 10.1007/s10654-005-4266-7. Eur J Epidemiol. 2005. PMID: 16121760

9

Reduced risk of hip fracture in women with endometrial cancer.

Persson I, Naessén T, Adami HO, Bergström R, Lagrelius A, Möllerström G, Pettersson B, von Hamos K. Persson I, et al. Int J Epidemiol. 1992 Aug;21(4):636-42. doi: 10.1093/ije/21.4.636. Int J Epidemiol. 1992. PMID: 1521965

10

Hormone replacement therapy and major risk factors for reproductive cancers, osteoporosis, and cardiovascular diseases: evidence of confounding by exposure characteristics.

Persson I, Bergkvist L, Lindgren C, Yuen J. Persson I, et al. J Clin Epidemiol. 1997 May;50(5):611-8. doi: 10.1016/s0895-4356(97)00004-8. J Clin Epidemiol. 1997. PMID: 9180654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters